Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹6 Cr
Revenue (TTM)
₹0 Cr
Net Profit (TTM)
₹0 Cr
ROE
0 %
ROCE
0 %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
45.32
EV/EBITDA
-840.9
Div. Yield
0 %
Debt to Equity
-0
Book Value
₹--
EPS
₹-0
Face value
10
Shares outstanding
5,729,120
CFO
5.78 Cr
EBITDA
-4.85 Cr
Net Profit
-14.70 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Manufacture of medical and dental instruments and supplies
Incorporated
1988
Chairman
--
Managing Director
--
Headquarters
Hyderabad, Telangana
Website
--
Annual Reports
Since, TTM earnings of CDR Medical Inds Ltd is negative, P/E ratio is not available.
The P/B ratio of CDR Medical Inds Ltd is 0.38 times as on 10-May-2000, a 94 discount to its peers’ median range of 6.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2011
|
0.00
|
0.00
|
|
2010
|
0.00
|
0.00
|
|
2008
|
0.00
|
0.00
|
|
2007
|
0.00
|
0.00
|
|
2005
|
0.00
|
0.00
|
The 52-week high and low of CDR Medical Inds Ltd are Rs -- and Rs -- as of 05-Apr-2026.
CDR Medical Inds Ltd has a market capitalisation of ₹ 6 Cr as on 10-May-2000. As per SEBI classification, it is a company.
Before investing in CDR Medical Inds Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.